Literature DB >> 1645387

Homogeneous susceptibility of distinct human herpesvirus 6 strains to antivirals in vitro.

H Agut, J T Aubin, J M Huraux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1645387     DOI： 10.1093/infdis/163.6.1382

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  12 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Genome-Wide Approach to the CD4 T-Cell Response to Human Herpesvirus 6B.

Authors:  Derek J Hanson; Olga Tsvetkova; Guilhem F Rerolle; Alexander L Greninger; Allesandro Sette; Lichen Jing; Victoria L Campbell; David M Koelle
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

4.  Successful ganciclovir therapy in a patient with human herpesvirus-6 encephalitis after unrelated cord blood transplantation: usefulness of longitudinal measurements of viral load in cerebrospinal fluid.

Authors:  K Hirabayashi; Y Nakazawa; Y Katsuyama; T Yanagisawa; S Saito; K Yoshikawa; T Shigemura; K Sakashita; M Ichikawa; K Koike
Journal:  Infection       Date:  2012-09-13       Impact factor: 3.553

5.  Significance of herpesvirus 6 in BAL fluid of hematology patients with acute respiratory failure.

Authors:  E Mariotte; D Schnell; C Scieux; F Agbalika; J Legoff; P Ribaud; N Boissel; B Schlemmer; E Azoulay
Journal:  Infection       Date:  2011-05-03       Impact factor: 3.553

Review 6.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

7.  Rate of detection of human herpesvirus-6 at different stages of HIV infection.

Authors:  A Gautheret; J T Aubin; V Fauveau; W Rozenbaum; J M Huraux; H Agut
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

Review 8.  Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  A J Wagstaff; D Faulds; K L Goa
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

9.  Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.

Authors:  Joshua A Hill; Sophia Koo; Belisa B Guzman Suarez; Vincent T Ho; Corey Cutler; John Koreth; Philippe Armand; Edwin P Alyea; Lindsey R Baden; Joseph H Antin; Robert J Soiffer; Francisco M Marty
Journal:  Biol Blood Marrow Transplant       Date:  2012-05-04       Impact factor: 5.742

Review 10.  Meningoencephalitis caused by human herpesvirus-6 in an immunocompetent adult patient: case report and review of the literature.

Authors:  D Torre; F Speranza; R Martegani; P Ferrante; E Omodeo-Zorini; R Mancuso; G P Fiori
Journal:  Infection       Date:  1998 Nov-Dec       Impact factor: 7.455
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.